Stay updated on GLPG1205 in IPF: Effective & Safe Clinical Trial
Sign up to get notified when there's something new on the GLPG1205 in IPF: Effective & Safe Clinical Trial page.

Latest updates to the GLPG1205 in IPF: Effective & Safe Clinical Trial page
- Check2 days agoChange DetectedThe page's bottom revision label has been updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe sponsor designation was updated from Galapagos NV to Lakefront Biotherapeutics NV. This change updates who is listed as the sponsor and responsible party for the IPF GLPG1205 trial.SummaryDifference0.2%

- Check23 days agoChange DetectedA new revision tag, v3.5.4, was added to replace the previous v3.5.3 in the page's revision history. This indicates the page was updated to a new version, with no evident changes to the study content from the provided context.SummaryDifference0.0%

- Check45 days agoChange DetectedUpdates add small informational/resource headings related to idiopathic pulmonary fibrosis and revise the displayed site release/version label. A previous revision number reference is removed, indicating a non-content site update rather than a change to the trial’s study information.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedDeleted the 'Interstitial Lung Disease 2' reference and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%

Stay in the know with updates to GLPG1205 in IPF: Effective & Safe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1205 in IPF: Effective & Safe Clinical Trial page.